Reporter phage and breath tests: Emerging phenotypic assays for diagnosing active tuberculosis, antibiotic resistance, and treatment efficacy

Journal of Infectious Diseases

Volumn 204, Issue SUPPL. 4, 2011, Pages

  Jain, Paras ^a   Thaler, David S ^a   Maiga, Mamoudou ^b   Timmins, Graham S ^c   Bishai, William R ^b,d   Hatfull, Graham F ^e   Larsen, Michelle H ^a,f   Jacobs, William R ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF NEW MEXICO   (United States)

^d UNIVERSITY OF KWAZULU NATAL   (South Africa)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f Department of Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; BETA GALACTOSIDASE; GREEN FLUORESCENT PROTEIN; ISONIAZID; RIFAMPICIN; UREASE;

ANTIBIOTIC RESISTANCE; BACTERIAL METABOLISM; BACTERIOPHAGE; BACTERIOPHAGE TYPING; BACTERIUM CULTURE; BREATH ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; ENZYME ACTIVITY; EXPIRED AIR; GENETIC TRANSCRIPTION; HUMAN; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; REPORTER PHAGE ASSAY; REVIEW; RNA TRANSLATION; SPUTUM ANALYSIS; TREATMENT RESPONSE; TUBERCULOSIS;

ANIMALS; ANTITUBERCULAR AGENTS; BREATH TESTS; FLOW CYTOMETRY; GENES, REPORTER; HUMANS; MICROBIAL SENSITIVITY TESTS; MYCOBACTERIOPHAGES; MYCOBACTERIUM TUBERCULOSIS; PHENOTYPE; RATS; TUBERCULOSIS;

EID: 80054735136     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir454     Document Type: Review

References (79)

1. Hassim S, Shaw PA, Sangweni P, et al. Detection of a substantial rate of multidrug-resistant tuberculosis in an HIV-infected population in South Africa by active monitoring of sputum samples. Clin Infect Dis 2010; 50:1053-9.
2. Cohen T, Murray M, Wallengren K, Alvarez GG, Samuel EY, Wilson D. The prevalence and drug sensitivity of tuberculosis among patients dying in hospital in KwaZulu-Natal, South Africa: a postmortem study. PLoS Med 2010; 7:e1000296.
3. Relman D, Hamburg M, Choffnes E, Mack A, eds. Microbial evolution and co-adaptation: a tribute to the life and scientific legacies of Joshua Lederberg. Washington, DC: National Academies Press, 2009:310.
4. Keeler E, Perkins MD, Small P, et al. Reducing the global burden of tuberculosis: the contribution of improved diagnostics. Nature 2006; 444(Suppl 1):49-57.
5. Bishop PJ, Neumann G. The history of the Ziehl-Neelsen stain. Tubercle 1970; 51:196-206.
6. Allen JL. A modified Ziehl-Neelsen stain for mycobacteria. Med Lab Sci 1992; 49:99-102.
7. Moore DA, Roper MH. Diagnosis of smear-negative tuberculosis in people with HIV/AIDS. Lancet 2007; 370:1033-4. (Pubitemid 47419017)
8. Day J. The roentgen-ray diagnosis of pulmonary tuberculosis. J Nat Med Assoc 1924; 17:21-8.
9. Zbinden A, Keller PM, Bloemberg GV. Rapid molecular detection of tuberculosis. N Engl J Med 2011; 364:183 author reply 184-5.
10. Diel R, Goletti D, Ferrara G, et al. Interferon-{gamma} release assays for the diagnosis of latent Mycobacterium tuberculosis infection: a systematic review and meta-analysis. Eur Respir J 2011; 37:88-99.
11. Kunnath-Velayudhan S, Salamon H, Wang HY, et al. Dynamic antibody responses to the Mycobacterium tuberculosis proteome. Proc Natl Acad Sci U S A 2010; 107:14703-8.
12. Helb D, Jones M, Story E, et al. Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, nearpatient technology. J Clin Microbiol 2010; 48:229-37.
13. Piatek AS, Tyagi S, Pol AC, et al. Molecular beacon sequence analysis for detecting drug resistance in Mycobacterium tuberculosis. Nat Biotechnol 1998; 16:359-63.
14. Edwards KJ, Metherell LA, Yates M, Saunders NA. Detection of rpoB mutations in Mycobacterium tuberculosis by biprobe analysis. J Clin Microbiol 2001; 39:3350-2. (Pubitemid 32830338)
15. Banada PP, Sivasubramani SK, Blakemore R, et al. Containment of bioaerosol infection risk by the Xpert MTB/RIF assay and its applicability to point-of-care settings. J Clin Microbiol 2010; 48:3551-7.
16. Blakemore R, Story E, Helb D, et al. Evaluation of the analytical performance of the Xpert MTB/RIF assay. J Clin Microbiol 2010; 48:2495-501.
17. Boehme CC, Nabeta P, Hillemann D, et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med 2010; 363:1005-15.
18. Melzer M. An automated molecular test for Mycobacterium tuberculosis and resistance to rifampin (Xpert MTB/RIF) is sensitive and can be carried out in less than 2 h. Evid Based Med 2011; 16:19.
19. Van Rie A, Page-Shipp L, Scott L, Sanne I, Stevens W. Xpert((R)) MTB/ RIF for point-of-care diagnosis of TB in high-HIV burden, resourcelimited countries: hype or hope? Expert Rev Mol Diagn 2010; 10:937-46.
20. WHO. Roadmap for rolling out Xpert MTB/RIF for rapid diagnosis of TB and MDR TB.
21. Hamilton-Miller JM. Antibiotic resistance from 2 perspectives: man and microbe. Int J Antimicrob Agents 2004; 23:209-12. (Pubitemid 38283587)
22. Sandgren A, Strong M, Muthukrishnan P, Weiner BK, Church GM, Murray MB. Tuberculosis drug resistance mutation database. PLoS Med 2009; 6:e2.
23. Hazbon MH, Brimacombe M, Bobadilla del Valle M, et al. Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis. Antimicrob Agents Chemother 2006; 50:2640-9. (Pubitemid 44198682)
24. Siddiqi S, Takhar P, Baldeviano C, Glover W, Zhang Y. Isoniazid induces its own resistance in nonreplicating Mycobacterium tuberculosis. Antimicrob Agents Chemother 2007; 51:2100-4. (Pubitemid 46903100)
25. Cox HS, McDermid C, Azevedo V, et al. Epidemic levels of drug resistant tuberculosis (MDR and XDR-TB) in a high HIV prevalence setting in Khayelitsha, South Africa. PLoS One 2010; 5:e13901.
26. Nunn P. Global incidence of MDR and XDR-TB. In: Institute of Medicine Forum on drug discovery, development and translation. Addressing the threat of drug -resistant TB: a realistic assessment. Geneva: Stop TB Department, WHO, 2008.
27. Sohn H, Minion J, Albert H, Dheda K, Pai M. TB diagnostic tests: how do we figure out their costs? Expert Rev Anti Infect Ther 2009; 7:723-33.
28. Arias M, Mello FC, Pavon A, et al. Clinical evaluation of the microscopic- observation drug-susceptibility assay for detection of tuberculosis. Clin Infect Dis 2007; 44:674-80.
29. Caviedes L, Lee TS, Gilman RH, et al. Rapid, efficient detection and drug susceptibility testing of Mycobacterium tuberculosis in sputum by microscopic observation of broth cultures. The Tuberculosis Working Group in Peru. J Clin Microbiol 2000; 38:1203-8. (Pubitemid 30140586)
30. Caviedes L, Moore DA. Introducing MODS: a low-cost, low-tech tool for high-performance detection of tuberculosis and multidrug resistant tuberculosis. Indian J Med Microbiol 2007; 25:87-8. (Pubitemid 46986150)
31. Moore DA. Future prospects for the MODS assay in multidrugresistant tuberculosis diagnosis. Future Microbiol 2007; 2:97-101. (Pubitemid 46766984)
32. Moore DA, Caviedes L, Gilman RH, et al. Infrequent MODS TB culture cross-contamination in a high-burden resource-poor setting. Diagn Microbiol Infect Dis 2006; 56:35-43. (Pubitemid 44294919)
33. Moore DA, Evans CA, Gilman RH, et al. Microscopic-observation drug-susceptibility assay for the diagnosis of TB. N Engl J Med 2006; 355:1539-50. (Pubitemid 44547806)
34. Park WG, Bishai WR, Chaisson RE, Dorman SE. Performance of the microscopic observation drug susceptibility assay in drug susceptibility testing for Mycobacterium tuberculosis. J Clin Microbiol 2002; 40:4750-2. (Pubitemid 35434981)
35. Shiferaw G, Woldeamanuel Y, Gebeyehu M, Girmachew F, Demessie D, Lemma E. Evaluation of microscopic observation drug susceptibility assay for detection of multidrug-resistant Mycobacterium tuberculosis. J ClinMicrobiol 2007; 45:1093-7. (Pubitemid 46626469)
36. Minion J, Pai M. Bacteriophage assays for rifampicin resistance detection in Mycobacterium tuberculosis: updated meta-analysis. Int J Tuberc Lung Dis 2010; 14:941-51.
37. Schwartz RS. Paul Ehrlich's magic bullets. N Engl J Med 2004; 350: 1079-80. (Pubitemid 38298987)
38. Daniel TM. Paul Ehrlich and the origins of chemotherapy. Int J Tuberc Lung Dis 2008; 12:113-4.
39. Ehrlich P. A method for staining the tubercle bacillu Aus dem Verein fur innere Medizin zu Berlin. Sitzung vom 1 Mai. Deutsche Medizinsche Wochenschrift 1882; 8:269-70.
40. Adams M. Bacteriophages. In: Hershey A, ed. New York: Interscience Publishers Inc, 1959:592.
41. Lederberg JS. Smaller Fleas. ad infinitum: Therapeutic bacteriophage redux. Proc Natl Acad Sci U S A 1996; 93:3167-8.
42. van Belkum A, Tassios PT, Dijkshoorn L, et al. Guidelines for the validation and application of typing methods for use in bacterial epidemiology. Clin Microbiol Infect 2007; 13(Suppl 3):1-46. (Pubitemid 47316257)
43. Dowdle WR, Hansen PA. A phage-fluorescent antiphage staining system for Bacillus anthracis. J Infect Dis 1961; 108:125-35.
44. Watson BB, Eveland WC. The application of the phage-fluorescent antiphage staining system in the specific identification of Listeria monocytogenes. I. Species specificity and immunofluorescent sensitivity of Listeria monocytogenes phage observed in smear preparations. J Infect Dis 1965; 115:363-9.
45. Watson BB, Eveland WC. The application of the phage-fluorescent antiphage staining system in the specific identification of Listeria monocytogenes. II. The use of the phage-fluorescent antiphage system in the specific identification of Listeria monocytogenes in tissues from experimentally infected animals. J Infect Dis 1966; 116:155-61.
46. Jacobs WR Jr, Tuckman M, Bloom BR. Introduction of foreign DNA into mycobacteria using a shuttle phasmid. Nature 1987; 327:532-5. (Pubitemid 17085824)
47. Jacobs WR Jr, Barletta RG, Udaniv R, et al. Rapid assessment of drug susceptibilities of Mycobacterium tuberculosis by means of luciferase reporter phages. Science 1993; 260:819-22. (Pubitemid 23167613)
48. Pearson RE, Jurgensen S, Sarkis GJ, Hatfull GF, Jacobs WR Jr. Construction of D29 shuttle phasmids and luciferase reporter phages for detection of mycobacteria. Gene 1996; 183:129-36. (Pubitemid 27007501)
49. Fullner KJ, Hatfull GF. Mycobacteriophage L5 infection of Mycobacterium bovis BCG: implications for phage genetics in the slow-growing mycobacteria. Mol Microbiol 1997; 26:755-66. (Pubitemid 27489337)
50. Riska PF, Jacobs WR Jr, Bloom BR, McKitrick J, Chan J. Specific identification of Mycobacterium tuberculosis with the luciferase reporter mycobacteriophage: use of p-nitro-alpha-acetylamino-beta-hydroxy propiophenone. J Clin Microbiol 1997; 35:3225-31. (Pubitemid 27505749)
51. Carriere C, Riska PF, Zimhony O, et al. Conditionally replicating luciferase reporter phages: improved sensitivity for rapid detection and assessment of drug susceptibility of Mycobacterium tuberculosis. J Clin Microbiol 1997; 35:3232-9. (Pubitemid 27505750)
52. Riska PF, Su Ya, Bardarov Svetoslav, et al. Rapid film-based determination of antibiotic susceptibilities of Mycobacterium tuberculosis strains by using a luciferase reporter phage and the Bronx Box. J Clin Microbiol 1999; 37:1144-9. (Pubitemid 29140627)
53. Bardarov S Jr, Dou H, Eisenach K, et al. Detection and drug-susceptibility testing of M. tuberculosis from sputum samples using luciferase reporter phage: comparison with the Mycobacteria Growth Indicator Tube (MGIT) system. Diagn Microbiol Infect Dis 2003; 45:53-61. (Pubitemid 36165030)
54. Hazbon MH, Guarin N, Ferro BE, et al. Photographic and luminometric detection of luciferase reporter phages for drug susceptibility testing of clinical Mycobacterium tuberculosis isolates. J Clin Microbiol 2003; 41:4865-9.
55. Banaiee N, Bobadilla-Del-Valle M, Bardarov S Jr, et al. Luciferase reporter mycobacteriophages for detection, identification, and antibioticsusceptibility testing of Mycobacterium tuberculosis in Mexico. J Clin Microbiol 2001; 39:3883-8. (Pubitemid 33029755)
56. Piuri M, Jacobs WR Jr, Hatfull GF. Fluoromycobacteriophages for rapid, specific, and sensitive antibiotic susceptibility testing of Mycobacterium tuberculosis. PLoS One 2009; 4:e4870.
57. Rybniker J, Nowag A, van Gumpel E, et al. Insights into the function of the WhiB-like protein of mycobacteriophage TM4-a transcriptional inhibitor of WhiB2. Mol Microbiol 2010; 77:642-57.
58. Stager CE, Gangadharam PR. Comparison of several culture media used for studies on mycobacteriophages. J Med Microbiol 1978; 11:187-91. (Pubitemid 8350538)
59. Friedman D, Olson E, Georgopoulos C, Tilly K, Herskowitz I, Banuett F. Interactions of bacteriophage and host macromolecules in the growth of bacteriophage lambda. Microbiol Rev 1984; 48:299-325. (Pubitemid 15218346)
60. Kwiatkowska S, Szkudlarek U, Luczynska M, Nowak D, Zieba M. Elevated exhalation of hydrogen peroxide and circulating IL-18 in patients with pulmonary tuberculosis. Respir Med 2007; 101:574-80. (Pubitemid 46196320)
61. Phillips M, Cataneo RN, Condos R, et al. Volatile biomarkers of pulmonary tuberculosis in the breath. Tuberculosis (Edinb) 2007; 87:44-52. (Pubitemid 44960164)
62. Adams KL, Steele PT, Bogan MJ, et al. Reagentless detection of Mycobacteria tuberculosis H37Ra in respiratory effluents in minutes. Anal Chem 2008; 80:5350-7.
63. Syhre M, Manning L, Phuanukoonnon S, Harino P, Chambers ST. The scent of Mycobacterium tuberculosis-part II breath. Tuberculosis (Edinb) 2009; 89:263-6.
64. Jassal MS, Nedeltchev GG, Lee JH, et al. 13[C]-urea breath test as a novel point-of-care biomarker for tuberculosis treatment and diagnosis. PLoS One 2010; 5:e12451.
65. McNerney R, Wondafrash BA, Amena K, Tesfaye A, McCash EM, Murray NJ. Field test of a novel detection device for Mycobacterium tuberculosis antigen in cough. BMC Infect Dis 2010; 10:161.
66. Phillips M, Basa-Dalay V, Bothamley G, et al. Breath biomarkers of active pulmonary tuberculosis. Tuberculosis (Edinb) 2010; 90:145-51.
67. Weetjens BJ, Mgode GF, Machang'u RS, et al. African pouched rats for the detection of pulmonary tuberculosis in sputum samples. Int J Tuberc Lung Dis 2009; 13:737-43.
68. Poling A, Weetjens BJ, Cox C, et al. Using giant African pouched rats to detect tuberculosis in human sputum samples: 2009 findings. Am J Trop Med Hyg 2010; 83:1308-10.
69. Han W, Wang T, Reilly AA, Keller SM, Spivack SD. Gene promoter methylation assayed in exhaled breath, with differences in smokers and lung cancer patients. Respir Res 2009; 10:86.
70. Jain R, Schriever CA, Danziger LH, Cho SH, Rubinstein I. The IS6110 repetitive DNA element of Mycobacterium tuberculosis is not detected in exhaled breath condensate of patients with active pulmonary tuberculosis. Respiration 2007; 74:329-33. (Pubitemid 46828144)
71. Bell GD,Weil J, Harrison G, et al. 14C-urea breath analysis, a non-invasive test for Campylobacter pylori in the stomach. Lancet 1987; 1:1367-8. (Pubitemid 17076258)
72. Gordon AH, Hart PD, Young MR. Ammonia inhibits phagosomelysosome fusion in macrophages. Nature 1980; 286:79-80.
73. Hart PD, Young MR. Ammonium chloride, an inhibitor of phagosomelysosome fusion in macrophages, concurrently induces phagosomeendosome fusion, and opens a novel pathway: studies of a pathogenic mycobacterium and a nonpathogenic yeast. J Exp Med 1991; 174: 881-9.
74. Damato JJ, Collins MT, McClatchy JK. Urease testing of mycobacteria with BACTEC radiometric instrumentation. J Clin Microbiol 1982; 15:478-80. (Pubitemid 12178886)
75. Toda T, Hagihara Y, Takeya K. A simple urease test for the classification of mycobacteria. Am Rev Respir Dis 1961; 83:757-61.
76. Zhang L, Mulrooney SB, Leung AF, et al. Inhibition of urease by bismuth( III): implications for the mechanism of action of bismuth drugs. Biometals 2006; 19:503-11. (Pubitemid 44291043)
77. Syhre M, Chambers ST. The scent of Mycobacterium tuberculosis. Tuberculosis (Edinb) 2008; 88:317-23.
78. Daigeler A. The cotton rat (Sigmodon hispidus hispidus) as an experimental animal in the diagnosis of tuberculosis. Z Hyg Infektionskr 1952; 135:588-91.
79. Banaiee N, Bobadilla-del-Valle M, Riska PF, et al. Rapid idenstification and susceptibility testing of Mycobacterium tuberculosis from MGIT cultures with luciferase reporter mycobacteriophages. J Med Microbiol 2003; 52:557-61. (Pubitemid 36871893)